Quarterly report pursuant to Section 13 or 15(d)

Note 1 - Nature of Business and Liquidity (Details Textual)

v3.23.3
Note 1 - Nature of Business and Liquidity (Details Textual) - USD ($)
Sep. 30, 2023
Dec. 31, 2022
 [1]
Percentage of Absolute Difference in Severe Oral Mucositis Prevention 15.00%  
Retained Earnings (Accumulated Deficit) $ (58,392,302) $ (51,804,021)
[1] Derived from the Company’s audited consolidated financial statements.